A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy and safety of sustained-release quetiapine fumarate (Seroquel) compared with placebo in the treatment of generalized anxiety disorder.

Trial Profile

A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy and safety of sustained-release quetiapine fumarate (Seroquel) compared with placebo in the treatment of generalized anxiety disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Dec 2011

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Generalised anxiety disorder
  • Focus Therapeutic Use
  • Acronyms TITANIUM
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Dec 2011 Results from a pooled analysis published in the Human Psychopharmacology: Clinical and Experimental.
    • 18 Jun 2011 Results published in the Journal of Clinical Psychopharmacology.
    • 28 Jun 2009 Planned pooled analysis of data from the GOLD, SILVER and TITANIUM trials presented at the 9th World Congress of Biological Psychiatry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top